Abstract: . . .  and Massad,M.G. Pharmacologic strategies for prevention of atrial fibrillation after open heart surgery. Ann. Thorac. Surg. 79, 728-740, (2005) 48. Aviles,R.J. et al. Inflammation as a risk factor for atrial fibrillation . Circulation 108, 3006-3010, (2003) 49. Chung,M.K. et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms . . .
. . .  Massad,M.G. Pharmacologic strategies for prevention of atrial fibrillation after open heart surgery. Ann. Thorac. Surg. 79, 728-740, (2005) 48. Aviles,R.J. et al. Inflammation as a risk factor for atrial fibrillation . Circulation 108, 3006-3010, (2003) 49. Chung,M.K. et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms . . .
. . .  interactions. Bioinformatics. 19, 376-382, (2003) 45. Coffey,C.S. et al. An application of conditional logistic regression and multifactor dimensionality reduction for detecting gene-gene interactions on risk of myocardial infarction: the importance of model validation. BMC. Bioinformatics. 5, 49, (2004) 46. Hastie, T, Tibshirani, R, and Friedman, J. H. The elements of statistical . . .
. . .  factor for atrial fibrillation . Circulation 108, 3006-3010, (2003) 49. Chung,M.K. et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation . Circulation 104, 2886-2891, (2001)  . . .
. . .  82-92, (2004) 35. Ritchie,M.D. et al. Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity. Genet. Epidemiol. 24, 150-157, (2003) Page 13 36. Hahn,L.W. and Moore,J.H. Ideal discrimination of discrete clinical endpoints using multilocus . . .
. . .  AF. In addition, cases and controls could be matched on a number of clinical factors to control for confounding. This study demonstrated the importance of looking for both main effects and interactive effects, as well as demonstrating the utility of MDR in analyzing multiple gene-gene and gene-environment interactions. Page 11 5. Acknowledgments This work was . . .
. . .  among estrogen-metabolism genes in sporadic breast cancer. Am J Hum. Genet 69, 138-147, (2001) 31. Cho,Y.M. et al. Multifactor-dimensionality reduction shows a two-locus interaction associated with Type 2 diabetes mellitus. Diabetologia 47, 549-554, (2004) 32. Tsai,C.T. et al. Renin-angiotensin system gene polymorphisms and atrial fibrillation . Circulation 109, . . .
--3000,7,214,3398,35343